In September, the U.S. Department of Health and Human Services, together with other federal agencies, announced proposed changes to the rules governing human subjects research. This Commentary discusses how the proposals would affect research using biospecimens that is essential to the future success of precision medicine. We argue that the proposed changes unnecessarily burden such research, without meaningfully advancing the interests of donors. They should be revised before being finalized.
MervisJ. New U.S. board proposed to tackle regulatory burden on research universities. Science, 2015;DOI: 10.1126/science.aad4606.
3.
The Secretary's Advisory Committee on Human Research Protections. Recommendations on the Notice of Proposed Rulemaking entitled “Federal Policy for the Protection of Human Subjects” (January5, 2016). Available at www.hhs.gov/ohrp/sachrp/commsec/attachmenta:recommendationsnprmletter1/5/16.html, accessed on January26, 2016.
4.
SchneiderCE. The Censor's Hand. Cambridge, MA: MIT Press; 2015.
5.
MarshJL, McMasterW, ParviziJ, et al.AOA symposium: Barriers (threats) to clinical research. J Bone Joint Surg Am, 2008; 90:1769–1776.
6.
WoottonSH, EvansPW, TysonJE. Unproven therapies in clinical research and practice: The necessity to change the regulatory paradigm. Pediatrics, 2013; 132:599–601.
7.
Federal Policy for the Protection of Human Subjects. 80 Fed. Reg. 53931. (September8, 2015). Available at https://federalregister.gov/a/2015-21756, accessed on November9, 2015.
8.
HudsonKL, CollinsFS. Bringing the common rule into the 21st century. N Engl J Med, 2015; 10:2293–2296.
9.
AllenMJ, PowersML, GronowskiKS, et al.Human tissue ownership and use in research: What laboratorians and researchers should know. Clin Chem, 2010; 56:1675–1682.
10.
BrothersKB, ClaytonEW. “Human non-subjects research”: Privacy and compliance. Am J Bioeth, 2010; 10:15–17.
11.
Federal Policy for the Protection of Human Subjects. 80 Fed. Reg. 53931, 53937.
12.
Federal Policy for the Protection of Human Subjects. 80 Fed. Reg. 53931, 53938.
13.
RubinsteinIS, HartzogW. Anonymization and risk. New York University Public Law and Legal Theory Working Papers. 530. Available at http://lsr.nellco.org/nyu_plltwp/530/, accessed on November13, 2015.
14.
SterlingRL. Genetic research among the Havusupai—A cautionary tale. Virtual Mentor, 2011; 13:113–117.
15.
SklootR. The Immortal Life of Henrietta Lacks. New York: Crown Publishers; 2010.
16.
KaufmanDJ, Murphy-BollingerJ, ScottJ, et al.Public opinion about the importance of privacy in biobank research. Am J Hum Genet, 2009; 85:643–54.
17.
GradyC, EcksteinL, BerkmanB, et al.Broad consent for research with biological samples: Workshop conclusions. Am J Bioeth, 2015; 15:34–42.
18.
JohnsonKJ, GehlertS. Return of results from genomic sequencing: A policy discussion of secondary findings for cancer predisposition. J Cancer Policy, 2014; 2:75–80.
19.
Federal Policy for the Protection of Human Subjects. 80 Fed. Reg. 53931, 53967.
